medigraphic.com
ISSN 1561-3070 (Electronic)

2022, Number 2

<< Back

Rev Cub Oftal 2022; 35 (2)

Primary ocular lymphoma vs orbital cellulitis in times of COVID-19

Castillo VC, López DN, Molinet VL, Pérez PAI

Language: Spanish
References: 15
Page: 1-8
PDF size: 192.22 Kb.


ABSTRACT

Solid neoplastic tumors of lymphoid tissue are characterized by accelerated proliferation of the lymphoreticular portion of the reticulum endothelial system, their worldwide incidence is 4/100,000 prevalent in females between 50-70 years of age, of unknown etiology, associated with helicobacter pylori, epstein barr and HIV. Clinically, symptoms B are present: fever, night sweats, weight loss, itching and asthenia, absent in the present case of a 46-year-old female patient who came to the ophthalmology office due to increased volume at the level of the appendages. of the left eye, painless proptosis and decreased vision, with an initial diagnosis of orbital cellulitis treated outpatiently without resolution. Intravenous antibiotic therapy was administered without clinical improvement, complementary radiological imaging studies, ultrasound, magnetic resonance imaging were performed with evidence of an anterolateral growth tumor image, ocular globe displacement, diameter greater than 57.3 mm, heterogeneous isointense characteristics, T1 sequence and flair, erosion of the internal wall of the orbit and the excisional biopsy reported primary non-Hodgkin type orbital annex lymphoma. A careful approach with complementary studies to rule out orbital neoplasms in patients with orbital cellulitis or dacryocystitis of torpid evolution is necessary at all times, regardless of the atypical conditions of a COVID-19 pandemic that make its management difficult.


REFERENCES

  1. Di Nisio L. Linfomas Orbitarios. Consejo argentino de oftalmología. Oftalmol Clin Exp. 2017 [acceso 28/01/2021];10(3):88-93. Disponible en: https://oftalmologos.org.ar/oce_anteriores/items/show/3751.

  2. Cabrera-Pérez C, Santana-Álvarez J, Rodríguez-Bencomo D, Olivera-Moran O, Miranda-Ramos M. Linfoma no Hodgkin con infiltración ocular: a propósito de un caso. Archivo Médico Camagüey. 2016 [acceso 28/01/2021];20(2). Disponible en: http://www.revistaamc.sld.cu/index.php/amc/article/view/42102.

  3. Chabay P, Lens D, Hassan R, Rodríguez M, Valvert F, Rivera I, et al. Lymphotropic Viruses EBV, KSHV and HTLV in Latin America: Epidemiology and Associated Malignancies. A Literature-Based Study by the RIAL-CYTED. Cancers. 2020. DOI: https://doi.org/10.3390/cancers120821663.

  4. Schottenfeld D, Beebe-Dimmer J. The cancer burden attributable to biologic agents. Ann Epidemiol. 2015;25:183-87. DOI: https://doi.org/10.1016/j.annepidem.2014.11.0164.

  5. Casulo C, Friedberg JW. Burkitt lymphoma- a rare but challenging lymphoma. Best Pract. Res. Clin. Haematol. 2018;31:279-84. DOI: https://doi.org/10.1016/j.beha.2018.07.0135.

  6. Shannon-Lowe C, Rickinson AB, Bell AI. Epstein-Barr virus-associated lymphomas. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2017:372. DOI: https://doi.org/10.1098/rstb.2016.02716.

  7. Cohen M, Vistarop AG, Huaman F, Narbaitz M, Metrebian F, De Matteo, et al. Cytotoxic response against Epstein Barr virus coexists with di-use large Bcell lymphoma tolerogenic microenvironment: Clinical features and survival impact. Sci. Rep. 2017;7:1-10. DOI: https://doi.org/10.1038/s41598-017-11052-z7.

  8. Corti M, Minue G, Campitelli A, Narbaitz M, Gilardi L. An Aggressive Plasmablastic Lymphoma of the Oral Cavity as Primary Manifestation of Acquired Immunodeficiency Syndrome: Case Report and Literature. Review. Int. Arch. Otorhinolaryngol. 2015;19:354-58. DOI: https://doi.org/10.1055/s-0034-13973358.

  9. Poles WA, Nishi EE, de Oliveira MB, Eugenio AIP, de Andrade TA, Campos A, et al. Targeting the polarization of tumor-associated macrophages and modulating mir-155 expression might be a new approach to treat di-use large B-cell lymphoma of the elderly. Cancer Immunol. Immunother. 2019,68:269-82. Disponible en: https://doi.org/10.1007/s00262-018-2273-2

  10. Guedes JCR, Cunha K, Machado J, Pinto LW. Nasal-type extranodal Tcell/NK lymphoma in association with hemophagocytic syndrome. An. Bras. Dermatol. 2018;93:422-25. DOI: https://doi.org/10.1590/abd1806-4841.2018709710.

  11. Beltran BE, Quinones P, Morales D, Malaga JM, Chavez JC, Sotomayor EM, et al. Response and survival benefit with chemoimmunotherapy in EpsteinBarr virus-positive di-use large B-cell lymphoma. Hematol. Oncol. 2018;36:93-97. DOI: https://doi.org/10.1002/hon.244911.

  12. Kalisz K, Alessandrino F, Beck R, Smith D, Kikano E, Ramaiya NH, et al. An update on Burkitt lymphoma: A review of pathogenesis and multimodality imaging assessment of disease presentation, treatment response, and recurrence. Insights Imaging 2019;10:56. DOI: https://doi.org/10.1186/s13244-019-0733-712.

  13. Pedraza RM, Arboleda LPA, Sanchez-Romero C, Quinones JAA, Tovar CJM, Henao JR, et al. Intraoral EBV-positive sporadic Burkitt lymphoma in an elderly patient with bilateral presentation. Autops. Case Rep. 2019, 9. DOI: https://doi.org/10.4322/acr.2019.11713.

  14. Ferlay J, Colombet M, Soerjomataram I, Siegel R, Torre L, Jemal A. Global and Regional Estimates of the Incidence and Mortality for 38 Cancers: GLOBOCAN 2018; World Health Organization, International Agency for Research on Cancer: Lyon, France. 2018. 14. DOI: https://doi.org/10.1002/ijc.2551614.

  15. Araujo I, Coupland SE. Primary vitreoretinal lymphoma: a review. Asia Pac J Ophthalmol (Phila). 2017;6:283-9. 15. DOI: https://doi.org/10.22608/APO.201715015.




2020     |     www.medigraphic.com